
Mannai Meds Private Limited
Founded in 2023 and headquartered in Tamil Nadu, India.
Founded in 2023 and headquartered in Tamil Nadu, India.
Mannai Meds Private Limited (MMPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2023 (One year and nine months 0 days old ). Its registered office is in Tiruvarur, Tamil Nadu, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Helan Samuel and Rasu Kumar serve as directors at the Company.
Tiruvarur, Tamil Nadu, India
+91-XXXXXXXXXX
U86201TN2023PTC161340
161340
Private Limited Indian Non-Government Company
21 Jun 2023
-
-
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Helan Samuel ![]() | Director | 21-Jun-2023 | Current |
Rasu Kumar ![]() | Additional Director | 01-Feb-2024 | Current |
Enhance accessibility to Mannai Meds's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Mannai Meds's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Helan Samuel is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mannai Meds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mannai Meds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mannai Meds's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rasu Ramesh Kumar was appointed as a Additional Director was appointed as a Additional Director on 01 Feb 2024 & has been associated with this company since 1 year 1 month .
Helan Hemavathy Felix Samuel was appointed as a Director was appointed as a Director on 21 Jun 2023 & has been associated with this company since 1 year 9 months .
Mannai Meds Private Limited was registered on 21 Jun 2023 with Roc Chennai & aged 1 year 9 months as per MCA records.
Mannai Meds Private Limited was incorporated on 21 Jun 2023.
The authorized share capital of Mannai Meds Private Limited is ₹ 1.50 M and paid-up capital is ₹ 10.00 K .
Currently 2 directors are associated with Mannai Meds Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mannai Meds Private Limited is No 7/1 V M D Complex V.O.C Road India, Mannargudi, Tamil Nadu, 614001.
The corporate identification number (CIN) of Mannai Meds Private Limited is U86201TN2023PTC161340 and the company number is 161340 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.
JD